A company of theRHÖN-KLINIKUM AG
Deutsch
A A A
DE
A A A
Deutsch
Philipps Universität Marburg Philipps Universität Marburg Fachbereich 20 – Medizin
Justus-Liebig-Universität Gießen Justus-Liebig-Universität Gießen Fachbereich 11 – Medizin
Bereichsnavigation

Previous
RHÖN-KLINIKUM AG | 09/23/2005

Conversion of preference shares into ordinary shares

  • Conversion of preference shares into ordinary shares admitted to trading on the Munich and Frankfurt stock exchanges completed
  • Listing to take place from 26 September 2005 

On 20 July 2005 the Annual General Meeting of RHÖN-KLINIKUM AG by a large majority adopted the resolution to convert the non-voting preference shares into ordinary shares. This step will end the preference and special dividend and entail a revision of the existing provisions of the Articles of Association. 

The move was well received among the shareholders. As expected, no objections were raised against the resolution. 

The “new” ordinary shares were admitted to trading on the Munich and Frankfurt stock exchanges on 23 September 2005. Deposits of preference shares held with depositary banks will be rebooked as ordinary shares at a ratio of 1 : 1 based on the balance as per 23 September 2005 in the evening. Shareholders whose preference shares are deposited with a credit institution do not have any action to take. Shareholders who hold their share certificates themselves are kindly asked to submit the certificates with dividend coupon no. 8ff with a credit institution to be forwarded to Bayerische und Hypo- Vereinsbank AG, Munich. In return these shareholders will receive a credit for their entitlement to ordinary shares on their deposit with a credit institution.

The listing of the “new” ordinary shares will begin on 26 September 2005.

The conversion of the preference shares into ordinary shares and the admission of the ordinary shares to the MDAX by Deutsche Börse improves the position of the RHÖN-KLINIKUM AG share within the index. “We are convinced the conversion will further boost the attractiveness of our shares among investors”, states Wolfgang Pföhler, chairman of the Board of Management of RHÖN-KLINIKUM AG, confidently.